Don't miss our holiday offer - up to 50% OFF!
How does REMATIB – 15 mg (Upadacitinib INN) work?
Composition: Each Extended-Release Tablet Contains Upadacitinib 15mg as Upadacitinib Hemihydrate. Indication: Rematib is a Janus Kinase (JAK) inhibitor indicated for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or…